Fatty acid synthase as a potential therapeutic target in cancer.
about
Targeting cellular metabolism to improve cancer therapeuticsParasitic Mistletoes of the Genera Scurrula and Viscum: From Bench to BedsideFatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancerA novel approach to the discovery of anti-tumor pharmaceuticals: searching for activators of liponecrosisLipid metabolic reprogramming in cancer cellsProgress toward overcoming hypoxia-induced resistance to solid tumor therapyLipid biology of breast cancerA human fatty acid synthase inhibitor binds β-ketoacyl reductase in the keto-substrate siteRecent evidence regarding triclosan and cancer riskHigh sensitivity of Giardia duodenalis to tetrahydrolipstatin (orlistat) in vitroDe novo fatty acid biosynthesis contributes significantly to establishment of a bioenergetically favorable environment for vaccinia virus infectionFrom obesity to cancer: a review on proposed mechanisms.Dissecting the Structural Elements for the Activation of β-Ketoacyl-(Acyl Carrier Protein) Reductase from Vibrio cholerae.Feasibility and antitumor efficacy in vivo, of simultaneously targeting glycolysis, glutaminolysis and fatty acid synthesis using lonidamine, 6-diazo-5-oxo-L-norleucine and orlistat in colon cancer.Increased phosphatidylethanolamine N-methyltransferase gene expression in non-small-cell lung cancer tissue predicts shorter patient survival.4-methylene-2-octyl-5-oxotetrahydrofuran-3-carboxylic acid (C75), an inhibitor of fatty-acid synthase, suppresses the mitochondrial fatty acid synthesis pathway and impairs mitochondrial functionAlpha-mangostin inhibits intracellular fatty acid synthase and induces apoptosis in breast cancer cells.FASN Inhibition and Taxane Treatment Combine to Enhance Anti-tumor Efficacy in Diverse Xenograft Tumor Models through Disruption of Tubulin Palmitoylation and Microtubule Organization and FASN Inhibition-Mediated Effects on Oncogenic Signaling and GNovel nuclear localization of fatty acid synthase correlates with prostate cancer aggressivenessInvolvement of de novo synthesized palmitate and mitochondrial EGFR in EGF induced mitochondrial fusion of cancer cells.The selective target of capsaicin on FASN expression and de novo fatty acid synthesis mediated through ROS generation triggers apoptosis in HepG2 cells.The contribution of RNA decay quantitative trait loci to inter-individual variation in steady-state gene expression levels.Chemical inhibition of acetyl-CoA carboxylase suppresses self-renewal growth of cancer stem cells.Screening of multiple myeloma by polyclonal rabbit anti-human plasmacytoma cell immunoglobulin.Effect of maternal exposure to endocrine disrupting chemicals on reproduction and mammary gland development in female Sprague-Dawley rats.Combining cross-metathesis and activity-based protein profiling: new β-lactone motifs for targeting serine hydrolasesModulation of tumor fatty acids, through overexpression or loss of thyroid hormone responsive protein spot 14 is associated with altered growth and metastasis.Myelopoietic efficacy of orlistat in murine hosts bearing T cell lymphoma: implication in macrophage differentiation and activationMetabolic features of clear-cell renal cell carcinoma: mechanisms and clinical implicationsEfficacy of massage therapy on pain and dysfunction in patients with neck pain: a systematic review and meta-analysis.New strategies in prostate cancer: targeting lipogenic pathways and the energy sensor AMPKMaf1 is a novel target of PTEN and PI3K signaling that negatively regulates oncogenesis and lipid metabolismRaman microspectroscopy of noncancerous and cancerous human breast tissues. Identification and phase transitions of linoleic and oleic acids by Raman low-temperature studies.Investigational cancer drugs targeting cell metabolism in clinical development.Colonic mucosal fatty acid synthase as an early biomarker for colorectal neoplasia: modulation by obesity and genderInhibition of the mevalonate pathway affects epigenetic regulation in cancer cells.Reverse TCA cycle flux through isocitrate dehydrogenases 1 and 2 is required for lipogenesis in hypoxic melanoma cells.Nuclear envelope expansion is crucial for proper chromosomal segregation during a closed mitosis.Inhibition of de novo Palmitate Synthesis by Fatty Acid Synthase Induces Apoptosis in Tumor Cells by Remodeling Cell Membranes, Inhibiting Signaling Pathways, and Reprogramming Gene Expression.Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma.
P2860
Q24596727-5D2350FD-699B-4BA6-A17B-DBAAA854EFE9Q26739988-E7893E4D-F7E8-45B4-B754-E3BDEBB083D7Q26747750-A8034130-6D20-4347-9611-9DD07E59DC22Q26774351-5D3566A8-9486-43FE-AE82-30FB9CB625A1Q26774859-46F1B09C-0B55-4533-ACC1-161F250534ABQ26796405-6906C425-EA3E-44F1-BF95-58502CA5A2ABQ27013858-126ED9CB-8B34-40C8-B32E-84B75C76C70AQ27694705-7D6EF6CD-D01A-49E6-A880-FBFC794EE8C9Q28397164-7D7D72A1-C28B-4B18-BE07-EE5AB01682FDQ28535443-7F98CAE4-DACE-4A0C-AB8D-9121F4FBA265Q28541249-A6EDE158-C1A5-4175-BEA8-29CD311BA2F4Q30241069-5AF075C8-974A-44B4-B4B4-051FAF7296FAQ30278363-6A59BCE0-9644-4780-866E-724D00BB2C77Q33598925-C44FE68C-4629-4630-8BF5-CE7D94E4E155Q33727484-BCA328C4-D17C-4434-91C9-D6D7E20BE7CCQ33761344-E0B57E9C-9AF3-42F2-A765-7F206D83F906Q33765134-3AA570F0-3846-455B-9E98-7042FEA5128EQ33809433-BA380464-8404-4CA4-BE67-FFB79E88E445Q33978062-9DBC16F2-42F5-46C7-963D-1A4D1424BCAFQ34028551-B4A445E5-E148-431D-8CA4-07B681BCE244Q34257357-6FC5BDEC-6A1C-4BCB-9CCF-B451F1086BC1Q34446672-16AC6454-464D-4B68-AFA1-C344E55DD741Q34483548-0F1ECB66-4ACB-4F36-88CC-EBE546700827Q34656161-22F39060-3A85-4375-AD97-4F56B42403E3Q34667293-42AF837E-C64C-4D6A-A59E-B5446331A86DQ34785627-63D21D3D-0407-4C7B-B398-EF4671A2AA44Q35000624-6591E4E0-A3C7-4BAD-8C98-5C3300874282Q35070248-B57A6D21-1C63-4AD6-89F1-5340899CD384Q35137857-9DCB324D-F4E0-49F6-962C-760DEE2A07E3Q35138738-21EFFDF2-528F-4F4F-848F-7680824AAA93Q35222084-D33F0904-5140-4856-83BC-C3A1E0F14E92Q35515702-A286985A-F52C-43F2-9ACB-D6EAA67DAF30Q35568742-315F3466-90CC-4421-8BE7-F021284E6973Q35615701-210EB2DC-2002-4E72-B61F-B57291ED898EQ35751139-9427E96D-B0EE-4A0C-8E6F-5234F72DB24DQ35856126-446E0A26-8211-4339-A839-B705E76133D7Q35897562-11C3E876-F846-4918-BC7C-56F51148A789Q35921649-85B8F610-36AD-42EA-8175-2948D300722CQ36038735-56286826-FD02-4549-9547-7973D5C24B11Q36122839-D32269D9-7232-47BA-8656-09988C7B88B4
P2860
Fatty acid synthase as a potential therapeutic target in cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Fatty acid synthase as a potential therapeutic target in cancer.
@ast
Fatty acid synthase as a potential therapeutic target in cancer.
@en
type
label
Fatty acid synthase as a potential therapeutic target in cancer.
@ast
Fatty acid synthase as a potential therapeutic target in cancer.
@en
prefLabel
Fatty acid synthase as a potential therapeutic target in cancer.
@ast
Fatty acid synthase as a potential therapeutic target in cancer.
@en
P2093
P2860
P356
P1433
P1476
Fatty acid synthase as a potential therapeutic target in cancer.
@en
P2093
Paul L Nguyen
Richard Flavin
Stephane Peluso
P2860
P304
P356
10.2217/FON.10.11
P407
P50
P577
2010-04-01T00:00:00Z